5 Best Brain-Computer Interface Stocks to Buy

In this article, we will take a look at the 5 Best Brain-Computer Interface Stocks to Buy. For a deeper discussion and an extended list, please see the 10 Best Brain-Computer Interface Stocks to Buy.

Pixabay/Public Domain

5. Medtronic plc (NYSE:MDT)

Number of Hedge Fund Holders: 60

On June 8, Medtronic plc (NYSE:MDT) Chairman and CEO Geoffrey Martha said on Fox Business Network’s The Claman Countdown that the company now expects a $250 million tariff hit for fiscal 2027, down from a prior $300 million estimate due to supply chain adjustments. It includes $75 million in the first quarter.

Martha noted the figure could change given new US tariff threats targeting multiple trading partners emerge, saying, “we’ll have to re-evaluate that.”

He said tariffs remain “pretty meaningful,” surging year over year and adding pressure along with higher input costs such as fuel. He underlined that around 80% of  Medtronic plc (NYSE:MDT)’s supply chain and over 90% of R&D are based in the US.

Martha pointed to growth as a buffer with a 78% revenue jump in cardiac ablation alongside strength in pacemakers, surgical, and spine businesses.

He also said the medtech firm put in $2 billion in acquisitions over the past fiscal year and invests $5 billion to $6 billion annually in innovation.

Medtronic plc (NYSE:MDT) is a medical technology company. It works in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through Cardiovascular Portfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit segments.